Neurocrine Bioscienc (NASDAQ: NBIX)
| Last Price | $45.56 |
| Net Change | $-1.75 (-3.7%) |
| Bid | $42 |
| Ask Price | $47.8 |
| Open Price | $46.86 |
| Previous Close Price | $47.31 |
| High Price | $47.34 |
| Low Price | $45.41 |
| Number of Trades | 6,055 |
| Volume | 1,324,400 |
| Fifty Two Week High | $55.38 (2017-05-02) |
| Fifty Two Week Low | $37.35 (2016-12-29) |
| Average Daily Volume | 1,303,449 |
| Share Outstanding | 88,070 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $-0.9 (2017-05-09) |
| 2nd Quarter Earnings | $-0.51 (2017-02-14) |
| 3nd Quarter Earnings | $-0.43 (2016-11-02) |
| 4th Quarter Earnings | $-0.46 (2016-08-03) |
| PE Ratio | $0 |
| EPS Growth | $-57.73 |
| Recent Earnings | $-0.9 |
| Annual EPS | $-2.3 |
| Last Quarter EPS | $ |
| Market Capitalization | $4.01B |
| Insider Shareholders % | 0.048% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 88,070 |
| Inst. Shareholder % | 95.9% |
| Annual Net Income | $-0.2B |
| TTM Net Profit Margin | $0 |
| 1-Year Return | 3.83% |
| 3-Year Return | 207.01% |
| 5-Year Return | 477.44% |
| 5-Year Revenue Growth | -80.62% |
| 5-Year Earnings Growth | -343.28% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | -57.73% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 0.5 |
NBIX News & Stock Updates
June 6, 2017
The 3 Best Pharmaceutical Stocks to Buy in 2017April 12, 2017
Top Stocks to Watch Today: BDRBF, DAL, NBIXMarch 23, 2017
Top Stocks to Watch Today: SGYP, PVH, NBIX